Reliance will slash ₹10,000 genomic tests to ₹1,000

Reliance Industries is planning to slash the cost of genomic tests in India from about ₹10,000 to under ₹1,000, a nearly tenfold reduction aimed at making advanced genetic screening affordable for the masses. Leveraging its acquisition of a Bengaluru genomics firm, the move could democratize access to early disease detection and personalised health insights.